Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Leukemia Research|February 8, 2017
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AMLAminetou Mint Mohamed, Marie Balsat, Catherine Koering, et al.
The Lancet. Haematology|June 4, 2026
Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation studyMarie Donzel, Syrine Khedimallah, Sabrina Barriere, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 24, 2025
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic SyndromeRomain Stammler, Alexandre Vallée, Julien Rohmer, et al.
Pageof 3